The global restless legs syndrome market is projected to grow at a CAGR of 6.2% during the forecast period. The increase in the prevalence of restless legs syndrome (RLS) is a key factor responsible for the growth of the market. RLS is a disorder that is associated with the part of the nervous system that causes patients an urge to move the legs restlessly. According to the estimation of the National Institute of Neurological Disorders and Stroke (NIH), around 7-10 % of the US population has RLS.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/restless-legs-syndrome-market

Moreover, the rising geriatric population further boosts the growth of the global market. As per the UN (United Nations), by 2050 around 1 in 6 (16%) citizens will be over the age of 65 years, globally, which was 1 in 11 (9%) in 2019. Old age, obesity, and snoring conditions lead to an increase in the rate of various types of sleep disorders which will create significant demand for diagnosis and treatment for obstructive sleep-wake disorders shortly.

A Full Report of Restless Legs Syndrome Market is Available at: https://www.omrglobal.com/industry-reports/restless-legs-syndrome-market

However, the high cost of drugs and therapy used for the treatment of restless leg syndrome coupled with low healthcare budget in some developing countries may hinder the growth of the market. For instance, the annual cost of Rotigotine (Neupro), a drug to treat used to treat restless legs syndrome and periodic limb movement disorder can cost up to $5,300 per year in the US. Huge R&D expenditure by market players for the development of the novel intervention is anticipated to create a considerable opportunity for market growth.


The global restless legs syndrome market is segmented based on treatment and end-users. Based on treatment, the market is segmented into medication, therapy, devices. Based on end-user, the market is segmented into hospitals, home care, and others. Hospital is forecast to be the considerable segment in the end-user market owing to the higher lifecycle, better efficiency of the medical equipment in the hospitals.


Restless Legs Syndrome Market Segmentation
Global Restless Leg Syndrome Market by Treatment
• Medication
• Therapy
• Devices

Global Restless Legs Syndrome Market by End-User
• Hospitals
• Homecare
• Others


Restless Legs Syndrome Market – Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• Akorn, Inc.
• Arbor Pharmaceuticals, LLC
• Boehringer Ingelheim GmbH
• GlaxoSmithKline plc
• Glenmark Pharmaceuticals Ltd.
• Jazz Pharmaceuticals plc
• Kyowa Hakko Kirin Co. Ltd.
• LGM Pharma
• Mallinckrodt Pharmaceuticals
• Merck Co, Inc.
• Mylan N.V.
• Pfizer, Inc.
• Serina Therapeutics, Inc.
• Teva Pharmaceutical Industries, Ltd.
• UCB S.A.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/restless-legs-syndrome-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404